Press "Enter" to skip to content

Vol. 19, no 1. P. 48-53

Reports AIAS. Vol. 19, no 1. P. 48-53. ISSN 1726-9946

Contents of this issue

MEDICINE

Research Article

The clinical effectiveness of azithromycin antimicrobial therapy used for the treatment of acute bacterial sinusitis

Lovpache Z.N., Khulaev I.V., Khulaeva A.I.

Presented by academician of AIAS R.Kh. Keshokov

Federal State Budgetary Educational Institution of Higher Education «Kabardino-Balkarian State University named after H.M. Berbekov», Nalchik

      The objective of the present publication was to report the result of the evaluation of the clinical effectiveness of azithromycin (Sumamed) antimicrobial therapy used for the treatment of bacterial acute rhinsinusitis (ARS). Dynamics of the reversal of the clinical symptoms of bacterial ARS in the patients of the study group is described. Neither adverse side effects nor complications in response to the treatment were documented. 98.6% of the patients recovered from the disease within 7 days after the onset of the treatment. It is concluded that antimicrobial therapy with the use of azithromycin (Sumamed) based at the outpatient settings provides a highly efficient.

Keywords: acute sinusitis, antimicrobial therapy, azithromycin.

© Z.N. Lovpache,
I.V. Khulaev,
A.I. Khulaeva, 2019

Список литературы (ГОСТ)

 

      1. Овчинников А.Ю. О чем следует помнить практическому врачу для успешного лечения бактериального риносинусита. Дыхание. 2013. V. 2. Pp. 11-14.
      2. Рачина С.А., Козлов Р.С., Шаль Е.П., Решетько О.В., Палютин Ш.Х., Сулейманов С.Ш., Торопова И.А. Анализ практики применения антимикробных препаратов у амбулаторных пациентов с острым риносинуситом в различных регионах РФ. Российская ринология. 2012. V. 1. Pp. 8-12.
      3. Страчунский Л.C., Козлов С.Н. Макролиды в современной клинической практике. Смоленск: Русич, 1998.
      4. Ушкалова Е.А. Эффективность и безопасность азитромицина при лечении внебольничных пневмоний у детей. Фарматека, 2004.
      5. Федеральное руководство по использованию лекарственных средств: формулярная система. Под ред. Чучалина А.Г., Белоусова Ю.Б., Яснецова В.В. (XII). М.: Эхо, 2011.
      6. Amrol D. Single-dose azithromycin microsphere formulation: a novel delivery system for antibiotics // Int. J. Nanomedicine. 2007. 2(1). Pp. 9-12.
      7. Jacobs R.F, Maples H.D, Aranda J.V. Pharmacokinetics of intravenously administered azithromycin in pediatric patients // Pediatr Infect Dis J. 2005. 24(21). Pp. 34-39.
      8. Odenbolt-Tornqvist I, Lowdin E, Cars O. Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, larithromycin and azytromycin on respiratory tract pathogens. Antimicrob. Agets. Chemother. 1995. V. 39. Pp. 221-226.
      9. Bergan Т. Pharmacokinetics of newer macrolides. In: Neu H.C., Young L.S., Zinner S.H., Acar J.F. New Macrolides, Azalides, and Streptogramins in Clinical Practice. New York, 1995. Pp. 51-60.
      10. Liu P. Allaudeen H. Chandra R. Comparative pharmacokinetic of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended release regimen versus a 3 day Immediate-release regimen. Antimicrob Agents Chemother. 2007. 51(1). Pp. 103-109. 
      11. Лазарева H.B., Лузина E.B. Применение генериков в клинической практике глазами врачей терапевтического профиля. VII национальный конгресс терапевтов (ноябрь 7-9). М. 2012.

For citation. Lovpache Z.N., Khulaev I.V., Khulaeva A.I. The clinical effectiveness of azithromycin antimicrobial therapy used for the treatment of acute bacterial sinusitis. Reports Adyghe (Circassian) International Academy of Sciences. 2019, vol. 19, no. 1, pp. 48-53.

Read article

©​ | 2022 | Адыгская (Черкесская) Международная академия наук